about
Sustained maximal voluntary contraction produces independent changes in human motor axons and the muscle they innervateUbiquitin-Synaptobrevin Fusion Protein Causes Degeneration of Presynaptic Motor Terminals in MiceSynaptic vesicle recycling: steps and principlesCa2+-dependent regulations and signaling in skeletal muscle: from electro-mechanical coupling to adaptationSynaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophyChannelopathies of skeletal muscle excitabilityCongenital myasthenic syndromes: pathogenesis, diagnosis, and treatmentThe aging neuromuscular system and motor performanceThe extracellular region of Lrp4 is sufficient to mediate neuromuscular synapse formationA novel synaptic plasticity rule explains homeostasis of neuromuscular transmissionMuscle-derived collagen XIII regulates maturation of the skeletal neuromuscular junction.Distinct muscarinic acetylcholine receptor subtypes contribute to stability and growth, but not compensatory plasticity, of neuromuscular synapses.Are unreliable release mechanisms conserved from NMJ to CNS?Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7The nicotinic acetylcholine receptor and the Na,K-ATPase alpha2 isoform interact to regulate membrane electrogenesis in skeletal muscle.Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) geneDok-7 regulates neuromuscular synapse formation by recruiting Crk and Crk-LSkeletal muscle tissue engineering: methods to form skeletal myotubes and their applications.Motor neuron-specific overexpression of the presynaptic choline transporter: impact on motor endurance and evoked muscle activitySynaptic Pathophysiology and Treatment of Lambert-Eaton Myasthenic Syndrome.Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy.Recovery of altered neuromuscular junction morphology and muscle function in mdx mice after injuryEarly changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onsetIdentification of neuromuscular junctions by correlative confocal and transmission electron microscopy.Myasthenic syndrome caused by mutation of the SCN4A sodium channelForce characteristics of the rat sternomastoid muscle reinnervated with end-to-end nerve repairEffects of diet on synaptic vesicle release in dynactin complex mutants: a mechanism for improved vitality during motor disease.Pre- and postsynaptic changes in the neuromuscular junction in dystrophic mice.L-citrulline inhibits [3H]acetylcholine release from rat motor nerve terminals by increasing adenosine outflow and activation of A1 receptors.Single-pixel optical fluctuation analysis of calcium channel function in active zones of motor nerve terminalsThe control of neuromuscular transmission in health and disease.Distinct α2 Na,K-ATPase membrane pools are differently involved in early skeletal muscle remodeling during disuse.Homeostatic matching and nonlinear amplification at identified central synapses.The therapy of congenital myasthenic syndromes.Synergy between pairs of competitive antagonists at adult human muscle acetylcholine receptors.Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin AMyasthenia gravis induced by autoantibodies against MuSK.Cellular events in nicotine addiction.Donepezil improves episodic memory in young individuals vulnerable to the effects of sleep deprivation.The effect of plasma from muscle-specific tyrosine kinase myasthenia patients on regenerating endplates.
P2860
Q21132286-2B34CF02-9C20-4F26-BA14-D74EDDBA981FQ26269823-B37297A9-534D-45D3-BDF8-D573DB2061A8Q26825177-02FD36A4-3CB5-4C08-B0B8-15AEB78EA1BAQ27001582-53FB426B-93EC-48E5-919B-A0EB5A309F41Q27312456-461948D4-36C8-4C86-8BF1-8DB181DEE643Q28082428-92B403F5-A2C4-44EC-904D-337D7697477FQ28082722-19F134D3-E70A-4E93-88AA-CDEA452AB5A0Q28396043-E625DD63-B534-4FEC-AE95-3AF5FE5A135FQ28512839-555D734B-A657-4DE6-9CBB-8245CCCB3516Q28833653-667F9429-349B-4D9C-B8FB-C8D1804D3CD9Q30497006-1D884672-F522-499F-BD4E-427302E4F15EQ33655157-F3AF5315-39F0-4437-8BD9-4354D1682620Q33827714-6E2822FB-A1E7-44A4-98EA-83BBC31D0823Q34114589-B91D52DB-EE72-4F02-8E30-80DB3E011929Q34121222-D190DBBD-527A-4EB9-BA27-0B2B8B0090A8Q34152015-22028179-C3D9-4CD5-827A-115780D70CFDQ34244283-B9F041CA-39FE-4E1C-B578-FA61D3EED976Q34322871-76718088-AB65-4054-9057-902FD58AE98CQ34355414-9CB70E57-1E31-4C65-B96C-41C3681FCAEDQ34437216-5B8AACFD-023B-43C4-A048-23C05978910EQ34602175-34CD8F1F-7F98-4BB9-A985-C0765698EC0CQ34807765-139A8268-FD41-4BEE-9367-2854432B73D3Q34989403-AC1414E2-3317-48EB-A0DC-74D666AEDC5DQ35130069-5A2A4287-1EDF-4604-B930-C9E79A5750B8Q35163768-48788125-2725-4CC0-A8D9-9421311AC8F0Q35616179-35D751DA-A7A3-451C-B021-A60C3E62C130Q35954027-B07B778F-E9D7-4132-803A-9AAC4205CBBAQ36038762-CDFFFBF4-F1B2-42A2-AFFE-CA757F43AC19Q36052781-954F831B-FA15-4C1F-A55E-2A21DE95EF14Q36142039-9BD0EF5C-C625-4822-9EF4-19BD849E1D31Q36412247-896628BF-73F4-42CD-993C-C99D09D4DD2AQ36505279-33068FA1-F89E-4DC6-95B0-AEC31BCE5966Q36724228-59DB36C8-7E07-40FF-85A6-3E05351B48A2Q36774720-AA4A6E66-C64A-47C6-B992-8D411858604FQ36813566-AA2EC065-AD12-467D-B579-5EA6DA854CE7Q36882760-2FBEF04A-E459-45BF-AE0D-A79EC4679089Q37223749-006419F3-9B00-4FE2-9A44-E87BA6B97CFEQ37247103-BAE21D9E-54FD-440D-9742-2C82CA64B275Q37279144-797667FB-22A3-4A18-B7AE-18A321C865C8Q37362084-E00ABAAA-EDA7-4B6B-8F92-45A2845ACFB4
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Safety factor at the neuromuscular junction.
@ast
Safety factor at the neuromuscular junction.
@en
Safety factor at the neuromuscular junction.
@nl
type
label
Safety factor at the neuromuscular junction.
@ast
Safety factor at the neuromuscular junction.
@en
Safety factor at the neuromuscular junction.
@nl
prefLabel
Safety factor at the neuromuscular junction.
@ast
Safety factor at the neuromuscular junction.
@en
Safety factor at the neuromuscular junction.
@nl
P1476
Safety factor at the neuromuscular junction.
@en
P2093
P304
P356
10.1016/S0301-0082(00)00055-1
P577
2001-07-01T00:00:00Z